MarketPulse

biotech financing

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Mestag Therapeutics

Mestag Therapeutics Secures $40M to Advance FAP-Targeted Cancer Immunotherapy

Mestag Therapeutics closes $40M financing and appoints leadership to advance FAP-targeted cancer immunotherapy MST-0312 into Phase 1 clinical trials.
JNJclinical trialbispecific antibody
GlobeNewswire Inc.GlobeNewswire Inc.··Unknown

Unnatural Products Lands $45M Series B, Novartis Deal Worth $1.7B

Biotech startup Unnatural Products secures $45M Series B funding led by The Venture Collective and inks $1.7B milestone deal with Novartis for oral peptide therapeutics.
MRKARGXNVSmacrocyclic peptidesSeries B funding